ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE- 46 a Live Biotherapeutic Biologic Drug ...Middle East

ROCKVILLE, Md., Jan. 26, 2023 /PRNewswire/ -- ExeGi Pharma LLC, a leader in the development of live biotherapeutic drugs and probiotics, announced today that the FDA has cleared its Investigational New Drug (IND) application for its biologic drug candidate, EXE-346. This clearance allows...

Read More Details
Finally We wish PressBee provided you with enough information of ( ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE- 46 a Live Biotherapeutic Biologic Drug )

Also on site :

• ‘BBQ Brawl’ Shocker: Who Went Home After the Campfire Cowboy Feast Challenge?
• Occupation conducts military exercise on border with Jordan after completion of "Gilead" Division
• Numbrix 9 - June 30